Itchy Feet & Autoimmune Disease: What Women Need to Know

New Hope for Primary Biliary Cholangitis Patients as Funding Approved for promising Treatment

Recent approval of funding from the Ministry of Health for a novel medication offers a potential lifeline to individuals with primary biliary cholangitis (PBC) who do not respond to existing therapies. The drug,known as elafibranor,has demonstrated promising results in clinical trials,possibly alleviating symptoms and slowing disease progression.

PBC is an autoimmune disease primarily affecting women, with a striking nine-to-one ratio of female to male patients. This means that nine out of every ten individuals diagnosed with the condition are women, a pattern considered highly characteristic by medical professionals.

Estimates suggest that